As of 2021, approval from the National Pharmaceutical Control Agency (NPRA) will be mandatory for clinical use of Cell & Gene Therapy Products (CGTP). 

• CTERM will only consider providing Contract Manufacturing Services for sponsors with Clinical Trial Exemption / Clinical Trial Import License issued by NPRA and for commercial products approved/ licensed by NPRA. 
• You are advised to verify with the National Pharmaceutical Control Agency (NPRA) directly on the approval for clinical use of any cells and gene therapy products (CGTP).      
• Consultation with qualified healthcare professionals is recommended before clinical use of such products. 
• Administration of such products in patients should be strictly performed by a qualified healthcare personnel / team.
• Any claims that cells/stem cells/exosomes produced by CTERM should be verified with us directly through email at ctermfper@ukm.edu.my or kpcterm@ukm.edu.my. 
• Any use of CTERM or UKM logo in marketing materials including brochures, presentations, social media, etc. should obtain written consent from CTERM or and by extention UKM legal department. Any misrepresentation of CTERM or its members are therefore liable to legal actions.